The CD8+ T cell tolerance checkpoint triggers a distinct differentiation state defined by protein translation defects

Authors:

Abstract
No abstract available
Funding Information
  • Australian Cancer Research Foundation (RGY0065/2018)
  • Victorian Cancer Agency (21019)
  • Cancer Research Trust New Zealand
  • AstraZeneca
  • Ministry of Education, Culture, Sports, Science and Technology
  • Japan Agency for Medical Research and Development
  • Bristol-Myers Squibb
  • Volkswagen Foundation
  • HHMI
  • HFSP
  • NHMRC (2008542, APP1121643, 2017420, APP1128416)